Background
==========

Hypertension is now recognized as a major contributor to the global burden of disease and global mortality.[@suz064-B1] In Nigeria, like in most African countries, hypertension is the foundation of cardiovascular disease. In a recent meta-analysis of blood pressure (BP) surveys in Nigeria, the documented overall prevalence of hypertension was 28.9% (95% CI 21.1--32.8%), with a prevalence of 29.5% (95% CI 24.8--34.3%) among men and 25.0% (95% CI 20.2--29.7%) among women.[@suz064-B2] There were about 20 million cases of hypertension in the country in the year 2010. This is projected to rise to 39.1-million cases by the year 2030.[@suz064-B3] Regrettably, the rate of awareness, treatment, and control are abysmally low.[@suz064-B2] Hypertension and its complications are responsible for about 25% of emergency medical admissions in urban hospitals in the country and is the commonest clinical diagnosis in elderly Nigerians, senior executives, and army recruits. It is the commonest risk factor for stroke, heart failure, chronic kidney disease, and dementia. The burden of hypertensive-related eye disease is high, and hypertension in pregnancy contributes to the high maternal morbidity and mortality in the country. Furthermore, high BP is the commonest cause of sudden unexpected natural death in the country.[@suz064-B4]

Nigeria got involved in the May Measurement Month (MMM)17 project as a member of the International Society of Hypertension (ISH) through the Nigerian Hypertension Society (NHS). The NHS considers the MMM project as a worthy action knowing fully well the burden and impact of hypertension in the country and the possible role MMM can play in the detection, awareness, and treatment of hypertension.

Methods
=======

The study was coordinated by Professor Ayo Arije \[immediate past President of the NHS\] and was ably assisted by Dr Okechukwu Ogah who organized the mobilization of NHS members as well as the central collation of data at Ibadan. Nineteen sites participated in Nigeria, and these were from the six geopolitical regions of the country and the federal capital territory at Abuja and the economic centre of the country, in Lagos. These sites were: Ibadan, Osogbo, and Lagos (in the South West region), Zaria, Kano, Sokoto, and Kebbi (North West region); Bida, Ilorin, and Abuja (North-Central region). Others are Uyo (South-South region); and Abakaliki, Umuahia, Enugu, Awka, Aba, and Nnewi (South East region); and finally Gombe, Zamfara, and Maiduguri (North-East region). Many investigators as well as volunteers were involved in the project. Each screening site conducted training using the training materials supplied by ISH. There was no other funding aside from the OMRON BP monitors donated by OMRON and T-shirts supplied by the ISH.

It was an opportunistic cross-sectional survey of participants who were 18 years and above, and this was carried out in the month of May, 2017. Screenings were conducted in public places after a session of public messages and this occurred most of the days of the month. Omron BP monitors (Omron M3 Intellisense) were used mostly and supplemented by mercury BP sphygmomanometers in some centres. Blood pressures were measured after at least 5 min of rest. Hypertension was defined as a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or in those on treatment for BP.

All screening sites obtained ethics approval from their various ethics review committees or boards and all participants gave informed consent before screening. Detailed methodology, data management, and statistical analysis have been published elsewhere.[@suz064-B5]

Results
=======

A total of 19 904 participants were screened, including 9616 women (48.3%) and 7977 men (40.1%). The sexes of 11.6% were unknown. The mean age of the participants was 40.9 (SD 14.4) years and 90.3% were black Africans. A total of 2569 (12.9%) were on anti-hypertensive medications. Diabetes mellitus, previous myocardial infarction, previous stroke, current history of cigarette smoking, and alcohol use were reported in 4.0%, 0.5%, 0.8%, 4.8%, and 14.1%, respectively.

After imputation, the age and sex-standardized mean BP in the participants was 125.8/78.7 mmHg. The mean BP after excluding those on treatment was 124.3/78.1 mmHg and 138.7/85.7 mmHg in those on treatment. A total of 36.2% (6709 out of 18 530) of participants with available BP readings after imputation had hypertension. A total of 25.9% of the participants not receiving treatment (4140 out of 15 961) had hypertension. A total of 58.8% (1449 of 2466 participants) of participants receiving treatment had uncontrolled BP. After adjustment for sex and age and allowing for an interaction, BP was significantly higher in participants who were on BP medications, who had diabetes and in smokers, and alcohol users ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *[Figure S1A](#sup1){ref-type="supplementary-material"}*). Blood pressure also increased significantly with increasing body mass index (BMI) ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *[Figure S1B](#sup1){ref-type="supplementary-material"}*). Higher systolic BP was observed on weekends (Saturday and Sunday) and lowest on Monday ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *[Figure S2](#sup1){ref-type="supplementary-material"}*).

Discussion
==========

This large opportunistic screening programme revealed that about 36.2% of adult Nigerians were hypertensive, 12.9% of all the participants were on treatment and almost 60% of those receiving anti-hypertensive treatment had uncontrolled BP. The proportion of hypertensive subjects in this study is similar to recent randomized surveys and opportunistic screenings in various parts of the country where about one-third were found to be hypertensive and even higher in surveys that screened middle-aged and elderly populations. The treatment and control rates are also low. Such opportunistic screening can help in increasing the detection and awareness rates of hypertension in the country, provide opportunities for health education as well as referral of those detected to health facilities for further care. Day to day variation in BP as well as the relationship of BP to other cardiovascular disease risk factors such as age, BMI, use of BP lowering drugs, smoking, and alcohol history was similar to the global data. MMM17 provided an ideal opportunity for mobilization of health workers in different parts of the country towards a collective effort at improving the detection and awareness rates of hypertension in Nigeria. Since the project was an opportunistic screening, it could only provide the proportion of hypertensive participants but not prevalence since the sample was not randomly selected.
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